Olopatadine Ophthalmic
Olopatadine Ophthalmic Information
Find all the information of Olopatadine Ophthalmic medicine and drugs available in Pakistan. Read the pricing, side effects, usage, instructions and dosage of Olopatadine Ophthalmic by .
Olopatadine Ophthalmic
medicine,pricing, side effects of Olopatadine Ophthalmic medicine by company and complete information of medicines in pakistan here on this page including all packings, MG, dosage information. This list includes medicines and drugs over every region of Pakistan like Karachi, Lahore, Islamabad, Faisalabad, Rawalpindi, Multan, Peshawar, Quetta and other cities of Pakistan.About Olopatadine Ophthalmic
Olopatadine is a potent selective antiallergic/antihistaminic agent. It has multiple distinct mechanisms of action. It antagonises histamine (the primary mediator of allergic response in humans) and prevents histamine induced inflammatory cytokine production by human conjunctival epithelial cells. Data from in vitro studies suggest that it may act on human conjunctival mast cells to inhibit the release of pro-inflammatory mediators. In patients with patent nasolacrimal ducts, topical ocular administration of olopatadine was suggested to reduce the nasal signs and symptoms that frequently accompany seasonal allergic conjunctivitis. It does not produce a clinically significant change in pupil diameter.
Indications
Olopatadine is primarily indicated in conditions like Allergic conjunctivitis.
Contraindication
Olopatadine is contraindicated in conditions like Hypersensitivity to any component of product.
Side Effects
The symptomatic adverse reactions produced by Olopatadine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weakness, Dizziness, Tiredness, Headache, Nausea, Blurred vision, Cough, Asthenia, Dermatitis, Rhinitis, Eye irritation, Photophobia, Dryness of eye, Burning eyes, Eye Pain, Sinusitis, Flu like syndrome, Dryness of nose, Hyperemia, Foreign body sensation, Increased tearing, Lids edema, Infection, Back pain, dizziness, stingling, stingling, Weakness.
Warnings
Do not instill olopatadine hydrochloride ophthalmic solution while wearing contact lenses, but to wait for 10 minutes after instillation before inserting contact lenses. Do not touch the eyelids or surrounding areas with the dropper tip of the bottle. It is only for topical use. Olopatadine should be used with caution during lactation. It should not be used to treat contact lens related irritation.
High Risk Groups
Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, and Geriatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Dosage
Olopatadine Ophthalmic Dosage for Adults
Dose | 2.22 to 0 mg/ml |
Single Dose | 1.1 (1.11) |
Frequency | 24 hourly |
Route | opthalmic |
Note: The dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. |
Olopatadine Ophthalmic Dosage for Neonatal
Dose | 2.22 to 0 mg/ml |
Single Dose | 1.1 (1.11) |
Frequency | 24 hourly |
Route | opthalmic |
Note: The dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. |
Olopatadine Ophthalmic Dosage for Paedriatic
Dose | 2.22 to 0 mg/ml |
Single Dose | 1.1 (1.11) |
Frequency | 24 hourly |
Route | opthalmic |
Note: The dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 ho |
Brands
Community Contribution
Do you know any authentic drug which is not listed here? Please let us know.